For the Irish playwright and screenwriter, see Nancy Harris.
Nancy Lee Harris is an educator as well as a well-established medical professional. She currently serves as a professor of pathology at Harvard Medical School. She is also a physician at Massachusetts General Hospital and an editor with the New England Journal of Medicine . She was trained at multiple different hospitals; however, the majority of her adult life has been spent working in Boston, Massachusetts. Throughout her life she has held many notable positions including but not limited to: Director of Hematopathology, Director of Surgical Pathology, Director of Anatomic Pathology, Director of Anatomic and Clinical Pathology Residency Program, and Director of Hematopathology Fellowship Program. [1] Harris is an important and distinguished medical provider in the Greater Boston area and focuses her research on blood malignancies and lymphoid neoplasms.
She is the wife of Jay R. Harris, who is a radiation oncology professor at Harvard Medical School. One son Dan Harris, is the co-anchor of the weekend edition of Good Morning America and married to Dr. Bianca Harris. Another son, Matthew Carmichael Harris is a venture capitalist and married to filmmaker Jessica Glass.
Nancy Lee Harris performed her internship in Internal Medicine at Washington University Barnes-Jewish Hospital. [1] She then moved to Boston and completed her residency in Anatomic and Clinical pathology at Beth Israel Deaconess Medical Center. [2] Harris rounded out her education by completing a fellowship in Hematopathology at Massachusetts General Hospital and is currently board certified in Anatomy pathology and Clinical pathology. [2]
Harris joined Massachusetts General Hospital in 1980 and has since held a variety of different positions. She started off as the Director of Hematopathology and remained the director until 2009. [1] In 1985, she also became the Director of Surgical Pathology until 1992 when she transitioned to the Director of Anatomic Pathology. She remained the Director of Anatomic Pathology until 1998. [1] In 1996, although she was already the Director of Hematopathology and the Director of Anatomic Pathology, Harris added a third title: Director of Anatomic and Clinical Pathology Residency Program. [1] Harris was in charge of the residency program until 2001. [1] When arriving in 1980, Harris also took on the job of being the Director of Hematopathology Fellowship Program until 2004. [1] Harris now serves as the editor of case records of Massachusetts General Hospital for the New England Journal of Medicine (NEJM). [3]
Harris mainly focuses her research on blood malignancies like lymphoma; however, she is also interested in lymphoid neoplasms. [2] Along with the World Health Organization and other scientists, Harris helped to develop the Revised European American Classification of Lymphoid Neoplasms around 2001. [4] This was the first time anyone had come to an international consensus on neoplasm taxonomy. [4] The Revised European American Classification of Lymphoid Neoplasms was updated in 2008. [5]
A second edition of the Hematopathology reference book was published by Harris and her fellow international experts in September 2016. [6] The book includes updated diagnostic techniques as well as suggestions for molecular and genetic testing. [6] In the last 5 years on top of helping to author this new reference book, Harris has been published over 21 times on PubMed. [7]
Harris became the editor for NEJM of the case records found in Massachusetts General Hospital beginning in 2002 and has since discussed 38 pathological mysteries in her first 10 years. [3] However, because of rapid technological advancement as well as the development of new diagnostic tools, pathological mysteries are becoming harder and harder to find leaving Harris with a smaller sample size of mysteries to review. [3]
For all of her hard work, outstanding professional career, and contributions to medicine, Harris was awarded the J. E. Wallace Sterling Lifetime Achievement Award in Medicine from Stanford University. [4]
Pathology is the study of disease and injury. The word pathology also refers to the study of disease in general, incorporating a wide range of biology research fields and medical practices. However, when used in the context of modern medical treatment, the term is often used in a narrower fashion to refer to processes and tests that fall within the contemporary medical field of "general pathology", an area that includes a number of distinct but inter-related medical specialties that diagnose disease, mostly through analysis of tissue and human cell samples. Idiomatically, "a pathology" may also refer to the predicted or actual progression of particular diseases, and the affix pathy is sometimes used to indicate a state of disease in cases of both physical ailment and psychological conditions. A physician practicing pathology is called a pathologist.
Anatomical pathology (Commonwealth) or anatomic pathology (U.S.) is a medical specialty that is concerned with the diagnosis of disease based on the macroscopic, microscopic, biochemical, immunologic and molecular examination of organs and tissues. Over the 20th century, surgical pathology has evolved tremendously: from historical examination of whole bodies (autopsy) to a more modernized practice, centered on the diagnosis and prognosis of cancer to guide treatment decision-making in oncology. Its modern founder was the Italian scientist Giovanni Battista Morgagni from Forlì.
Forensic pathology is pathology that focuses on determining the cause of death by examining a corpse. A post mortem examination is performed by a medical examiner or forensic pathologist, usually during the investigation of criminal law cases and civil law cases in some jurisdictions. Coroners and medical examiners are also frequently asked to confirm the identity of remains.
Dermatopathology is a joint subspecialty of dermatology and pathology or surgical pathology that focuses on the study of cutaneous diseases at a microscopic and molecular level. It also encompasses analyses of the potential causes of skin diseases at a basic level. Dermatopathologists work in close association with clinical dermatologists, with many possessing further clinical training in dermatology. The field was founded by German dermatologist and physician Gustav Simon, who published the first textbook on dermatopathology, 'Skin Diseases Illustrated by Anatomical Investigations', in 1848.
Clinical pathology is a medical specialty that is concerned with the diagnosis of disease based on the laboratory analysis of bodily fluids, such as blood, urine, and tissue homogenates or extracts using the tools of chemistry, microbiology, hematology, molecular pathology, and Immunohaematology. This specialty requires a medical residency.
An oral medicine or stomatology doctor/dentist has received additional specialized training and experience in the diagnosis and management of oral mucosal abnormalities including oral cancer, salivary gland disorders, temporomandibular disorders and facial pain, taste and smell disorders; and recognition of the oral manifestations of systemic and infectious diseases. It lies at the interface between medicine and dentistry. An oral medicine doctor is trained to diagnose and manage patients with disorders of the orofacial region.
Hematopathology or hemopathology is the study of diseases and disorders affecting and found in blood cells, their production, and any organs and tissues involved in hematopoiesis, such as bone marrow, the spleen, and the thymus. Diagnoses and treatment of diseases such as leukemia and lymphoma often deal with hematopathology; techniques and technologies include flow cytometry studies and immunohistochemistry.
Loyola Medicine, also known as Loyola University Health System, is a quaternary-care system with a 61-acre (25 ha) main medical center campus in the western suburbs of Chicago, in the U.S. state of Illinois. The medical center campus is located in Maywood, 13 miles (21 km) west of the Chicago Loop and 8 miles (13 km) east of Oak Brook. The heart of the medical center campus is the Loyola University Medical Center. Also on campus are the Joseph Cardinal Bernardin Cancer Center Loyola Outpatient Center, Center for Heart & Vascular Medicine and Loyola Oral Health Center as well as the Loyola University Chicago Stritch School of Medicine, Loyola University Chicago Marcella Niehoff School of Nursing, Center for Translational Research and Education, and the Loyola Center for Fitness.
Zeynel A. Karcioglu is a medical and surgical practitioner, researcher and medical educator. He is a diplomate of the American Board of Ophthalmology, specializing in Ophthalmic Oncology and Pathology particularly in areas of retinoblastoma, external eye tumors, and primary and metastatic orbital neoplasms. Karcioglu is also residency and fellowship trained in Anatomic Pathology and Neuropathology and certified by the American Board of Pathology.
An orthopedic (orthopaedic) oncologist is a physician and surgeon who specializes in the diagnoses and treatment of primary benign and malignant tumors of the bones.
Juan Rosai was an Italian-born American physician who contributed to clinical research and education in the specialty of surgical pathology. He was the principal author and editor of a major textbook in that field, and he characterized novel medical conditions such as Rosai-Dorfman disease and the desmoplastic small round cell tumor. Rosai is also well-known because of his role as teacher, mentor and consultant to many American and international surgical pathologists.
Ruth Lillian Kirschstein was an American pathologist and science administrator at the National Institutes of Health (NIH). Kirschstein served as director of the National Institute of General Medical Sciences, deputy director of NIH in the 1990s, and acting director of the NIH in 1993 and 2000-2002.
Sharon Ann Whelan Weiss is an American pathologist who is best known for her contribution to the subspecialty of soft tissue pathology. She is the main author of Soft Tissue Tumors, one of the most widely used textbooks in the field of sarcoma and soft tissue pathology. She is also well known for her seminal descriptions of multiple soft tissue tumors, such as epithelioid hemangioendothelioma and pleomorphic hyalinizing angiectatic tumor of soft parts among others. She has also mentored and trained other well-known soft tissue pathologists.
Lynn Bry is a physician, anaerobic microbiologist, and microbial geneticist at Brigham & Women's Hospital, and Harvard Medical School. She has created multiple multi-institutional platforms to support scientific, clinical and educational activities, including the MadSci Network, Crimson prospective collection resource, Massachusetts Host-Microbiome Center, and Partners Healthcare-wide Pathogen Genomic Surveillance Program. She has also founded or co-founded successful start-up companies including iSpecimen and ConsortiaTX. She was awarded her MD and a PhD in Molecular Microbiology and Pathogenesis from Washington University School of Medicine. Her research studies host-microbiome interactions and their application to develop new therapeutics for human disease. She has authored or co-authored >70 peer-reviewed articles and book chapters, including original papers in Science detailing a molecular model of host-microbial cross-talk in the small intestine, and in Nature Medicine demonstrate therapeutic use of defined commensal microbes to reverse food allergies. Bry teaches medical school courses and is also a lecturer and mentor for the Project Success Program at Harvard Medical School.
Elaine Sarkin Jaffe is a senior National Cancer Institute (NCI) investigator at the National Institutes of Health (NIH) most well known for her contribution to hematopathology. She completed her medical education at Cornell University and the University of Pennsylvania, receiving her M.D. degree from University of Pennsylvania in 1969. After an internship at Georgetown University she joined NCI as a resident in anatomic pathology, and has been a senior investigator since 1974, focusing on the classification and definition of lymphomas. Jaffe's early work helped to provide a deeper understanding of the origin of lymphomas, especially follicular lymphoma. Her team notably elucidated the difference between T cell and B cell lymphomas.
Dr. Marcella Farinelli Fierro is a medical examiner and forensic pathologist. She was the former chief medical examiner of Virginia, appointed in 1994 and serving in this position until her retirement in 2008. She was the ninth woman certified in forensic pathology by the American Board of Pathology. Since retirement, Fierro has served as an educator, mentor, and adviser.
The American Board of Pathology (ABPath) is one of 24 member boards of the American Board of Medical Specialties. This organization was assembled in May 1936, under the approval of the Advisory Board for Medical Specialties (ABMS) and the American Medical Association (AMA) Council on Medical Education and Hospitals. It is the duty of the ABPath to grant certification in Anatomic Pathology, Clinical Pathology and/or Anatomic/Neuropathology to qualified Doctors of Medicine and Doctors of Osteopathic Medicine (M.D./D.O.).
Marcela V. Maus is an associate professor of medicine at Harvard Medical School and director of the Cellular Immunotherapy Program at Massachusetts General Hospital. She works on immunotherapy for the treatment of cancer, using genetically engineered T cells to target malignancies (cancer).
Lynn From was a Canadian physician who specialized in dermatology and skin pathology. From was the pathologist-in-chief at Toronto's Women's College Hospital from 1981 to 1992 and the head of dermatology from 1993 to 2000.
Geraldine Sowinski Pinkus is an American pathologist who serves as Director of Hematopathology at Brigham and Women's Hospital. She is also Professor of Pathology at Harvard Medical School.